Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03877692 · ClinicalTrials.gov registry record · Phase 4
Acute Control of Chronic Hypertension
A Phase 4 study, sponsored by Albany Medical College.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03877692: Clinical Trial Phase 4 study, sponsored by Albany Medical College.
NCT03877692 is a Phase 4 study that was terminated before completion, run by Albany Medical College. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03877692, a Phase 4 study, was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
Primary Outcome
length of time in minutes between IV labetalol treatment and non-severe blood pressure
Interventions
- DRUG Experimental dosing of labetalol
- OTHER Standard dosing of labetalol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2020-07-20 |
| Phase | Phase 4 |
Why NCT03877692 stopped before completion
NCT03877692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental dosing of labetalol is the first listed.
NCT03877692 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03877692 about?
NCT03877692 is a clinical study titled "Acute Control of Chronic Hypertension". The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dos...
What is the current status of trial NCT03877692?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2019-02-18. Estimated completion is 2020-07-20.
What interventions are being tested in trial NCT03877692?
The interventions under investigation include: Experimental dosing of labetalol (DRUG), Standard dosing of labetalol (OTHER).
Who is sponsoring clinical trial NCT03877692?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03877692's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI